Last reviewed: June 9, 2026
Last updated: June 9, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide, a dual GLP-1 and GIP receptor agonist, has demonstrated weight loss of 20–22% in clinical trials when used as monotherapy. Some patients exploring complementary strategies ask whether adding NAD (nicotinamide adenine dinucleotide) supplements could amplify outcomes. This article examines the evidence, safety considerations, and whether PlexusDx personalization can guide this decision.
Understanding NAD and Tirzepatide Mechanisms
NAD is a coenzyme that powers cellular energy production and metabolic pathways, including sirtuins and PARPs involved in longevity and mitochondrial function. Tirzepatide works by activating GLP-1 and GIP receptors in the brain, reducing appetite and increasing insulin sensitivity in muscle and liver tissue. These mechanisms operate through different biological systems—NAD enhances intracellular energy and stress responses, while tirzepatide modulates satiety hormones and glucose metabolism.
Published research has not directly studied NAD supplementation alongside tirzepatide in weight loss populations. However, both compounds theoretically support metabolic health through distinct pathways. NAD precursors like NMN and NR have shown modest improvements in mitochondrial function and glucose tolerance in some studies, while tirzepatide's effects on weight and glycemic control are well-established in Phase 3 trials.
Safety Considerations When Combining NAD and Tirzepatide
No known direct pharmacological interactions exist between NAD supplements and tirzepatide injection. Tirzepatide does not inhibit or induce the enzymes responsible for NAD metabolism, and NAD precursors do not affect GLP-1 or GIP receptor signaling. However, combining any two active compounds requires medical oversight to monitor for cumulative effects on metabolism, gastrointestinal function, or unexpected responses.
Tirzepatide commonly causes nausea, vomiting, and appetite suppression—effects that may compound with certain NAD supplements if they alter gut pH or motility. Patients taking both should report any unusual gastrointestinal symptoms, fatigue, or metabolic changes to their healthcare provider. PlexusDx recommends consulting your clinical team before adding NAD to an active tirzepatide regimen to ensure alignment with your individual health profile and treatment goals.
What Clinical Evidence Shows About NAD Supplementation
NAD precursor supplements (NMN, NR, and nicotinamide) have demonstrated benefit in age-related metabolic decline and mitochondrial function in rodent and limited human studies. A 2021 trial found that NMN supplementation improved muscle insulin sensitivity in prediabetic women, while another study suggested NR supported endothelial function. These findings suggest NAD might support metabolic recovery, but evidence in active weight loss populations remains sparse.
The doses used in published research typically range from 250–1000 mg daily for NAD precursors, and effect sizes on weight loss have been modest to negligible when studied alone. No randomized controlled trials have measured the combined effect of NAD plus tirzepatide on body composition, metabolic rate, or long-term weight retention. Until such evidence emerges, the decision to combine these should be individualized based on your genetic predispositions and metabolic profile.
Personalized Weight Loss: How PlexusDx Precision Peptide Genetic Testing Can Guide Your Plan
PlexusDx Precision Peptide Genetic Test examines 14 metabolic pathways and 150+ genetic insights to identify how your body responds to GLP-1 agonists, GIP signaling, and mitochondrial efficiency genes. Key variants such as GLP1R rs6923761, GIPR rs1800437, and genes affecting NAD-dependent pathways (like SIRT1 and NAMPT) can reveal whether your genetic profile supports complementary NAD therapy alongside tirzepatide. This test costs $99 as an add-on after your first month of treatment and provides actionable data to optimize your regimen.
If your genetic profile shows reduced NAD synthesis capacity or mitochondrial stress markers, incorporating a modest NAD precursor supplement may support energy production and glucose handling while you're on tirzepatide. Conversely, if your genetic data suggests strong sirtuin activation and efficient NAD metabolism, adding extra NAD may offer minimal additional benefit. PlexusDx uses this personalization framework to help you avoid unnecessary supplements and focus spending on compounds matched to your biology.
Optimizing Weight Loss Without Unnecessary Combinations
Tirzepatide Injection from PlexusDx starts at $249/month and delivers proven, dose-escalated weight loss without requiring additional supplements for efficacy. The majority of patients achieve meaningful weight reduction through tirzepatide monotherapy, dietary consistency, and moderate physical activity. Adding NAD supplements should only be considered if you have identified mitochondrial dysfunction, persistent fatigue, or genetic evidence supporting NAD pathway support—not as a routine enhancement strategy.
PlexusDx offers Compounded Tirzepatide Injection through licensed 503A pharmacies, serves all 50 states without insurance, and accepts HSA/FSA funds for cost flexibility. If you're interested in exploring whether NAD supplementation aligns with your genetics and metabolic goals, request the Precision Peptide Genetic Test during your first month to receive a personalized recommendation. Your healthcare provider can then help you decide whether a specific NAD protocol deserves a trial alongside your tirzepatide therapy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is it safe to take NAD supplements while using tirzepatide?
There are no known direct interactions between NAD precursors and tirzepatide injection. However, combining any two active substances requires medical supervision. PlexusDx recommends informing your healthcare provider before adding NAD to ensure it aligns with your individual health status and tirzepatide response.
Will NAD help me lose more weight faster on tirzepatide?
Clinical evidence does not support NAD supplementation as a weight loss accelerator in humans. Tirzepatide alone has demonstrated 20–22% weight loss in Phase 3 trials. While NAD may support mitochondrial function and metabolic recovery, it has not been shown to enhance tirzepatide's weight loss effects in published studies.
How much does tirzepatide cost at PlexusDx, and what if I want to add supplements?
PlexusDx Compounded Tirzepatide Injection starts at $249/month—a flat rate regardless of your dose level. If you wish to explore personalized supplement recommendations, the Precision Peptide Genetic Test ($99 add-on) analyzes your NAD metabolism genes and mitochondrial efficiency to guide your decision.
What are the common side effects of tirzepatide, and could NAD worsen them?
Tirzepatide commonly causes nausea, vomiting, constipation, and reduced appetite. NAD supplements are generally well-tolerated, but some formulations may affect digestion. Monitor gastrointestinal symptoms closely if combining both, and report persistent issues to your provider.
Can the Precision Peptide Genetic Test tell me if I should take NAD with tirzepatide?
Yes. PlexusDx Precision Peptide Genetic Test examines 14 metabolic pathways, including NAD synthesis genes like NAMPT and SIRT1. If your results show reduced NAD pathway capacity or mitochondrial stress markers, your provider may recommend NAD support alongside tirzepatide. The test costs $99 after your first treatment month.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Semaglutide With B12: What It Is and Whether It Helps
How to Maximize Semaglutide Weight Loss: Your Comprehensive Guide